UnitedHealth Group Reports Q3 2026 Results and Raises Full-Year Guidance

Executive Summary

On October 13, 2026, UnitedHealth Group Incorporated (NYSE: UNH) filed Form 8-K under Item 2.02 detailing its third-quarter 2026 financial and operational performance, while raising full-year 2026 earnings guidance.

Key Financial Highlights

• Consolidated Revenues: $112.7 billion in Q3 2026 compared to $113.2 billion in Q3 2025.
• Earnings from Operations: $6.56 billion, reflecting a significant 52.1% increase compared to $4.32 billion in Q3 2025.
• Net Earnings Attributable to UNH Shareholders: $4.11 billion ($4.56 per diluted share) compared to $2.35 billion ($2.59 per diluted share) in Q3 2025.
• Adjusted Diluted EPS: $4.69 compared to $2.92 in Q3 2025.
• Medical Care Ratio (MCR): 88.4%, down 150 basis points from 89.9% in Q3 2025, supported by $610 million of favorable prior-period reserve development for 2026 service dates.
• Operating Cost Ratio: 12.8% versus 13.5% in Q3 2025, driven by operating efficiencies despite sustained technology and operational investments.
• Operating Cash Flow: $5.1 billion for the quarter (1.2x net income); nine-month operating cash flow reached $25.1 billion.

Segment Performance

• UnitedHealthcare:
  • Revenues: $86.33 billion (vs. $87.07 billion in Q3 2025).
  • Operating Earnings: $2.83 billion (operating margin 3.3%), up from $1.81 billion (2.1% margin) in Q3 2025.
  • Consumers Served: 48.3 million medical members.
• Optum:
  • Revenues: $66.88 billion (vs. $69.18 billion in Q3 2025).
  • Operating Earnings: $3.73 billion (operating margin 5.6%), up from $2.51 billion (3.6% margin) in Q3 2025.
  • Optum Health: Revenue of $22.91 billion; operating earnings of $735 million (vs. $41 million in Q3 2025).
  • Optum Insight: Revenue of $5.47 billion (+3% YoY); operating earnings of $1.28 billion.
  • Optum Rx: Revenue of $39.93 billion; operating earnings of $1.72 billion with 393 million adjusted scripts.

Balance Sheet & Capital Return

• Debt-to-Capital Ratio: 41.7% at September 30, 2026, targeting ~40% by year-end.
• Capital Allocation: Year-to-date share repurchases totaled $5.03 billion, and dividends paid reached $6.17 billion.
• Days Claims Payable: Stable at 47.0 days.

Guidance Update

UnitedHealth Group updated and raised its full-year 2026 outlook:

• Diluted GAAP EPS: Expected to be at least $19.50.
• Adjusted Diluted EPS: Raised to at least $20.50.